Press "Enter" to skip to content

Sun Pharma Q3 net doubles to ₹1,852 cr; declares interim dividend of ₹5.50 per share – Mint

Sun Pharma on Friday reported doubling of its consolidated net profit at 1,853 crore for the quarter ending 31 December, 2020. It was 914 crore in the year-ago period.

Consolidated total revenue from operations increased 8% to 8,837 crore as against 8,155 crore a year ago.

The company declared an interim dividend of 5.50 per share.

EBITDA for the quarter-ended December rose nearly 31% to 2,406 crore.

At 2:25 pm on Friday, the company’s scrip on NSE was trading 3.4% higher at 583.70.

Subscribe to Mint Newsletters

* Enter a valid email

* Thank you for subscribing to our newsletter.